157 related articles for article (PubMed ID: 22235027)
1. Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer.
Shen J; Wang D; Gregory SR; Medico L; Hu Q; Yan L; Odunsi K; Lele SB; Ambrosone CB; Liu S; Zhao H
Carcinogenesis; 2012 Mar; 33(3):604-12. PubMed ID: 22235027
[TBL] [Abstract][Full Text] [Related]
2. Associations between gene expression variations and ovarian cancer risk alleles identified from genome wide association studies.
Zhao H; Shen J; Wang D; Guo Y; Gregory S; Medico L; Hu Q; Yan L; Odunsi K; Lele S; Liu S
PLoS One; 2012; 7(11):e47962. PubMed ID: 23133607
[TBL] [Abstract][Full Text] [Related]
3. Replication study for the association of seven genome- GWAS-identified Loci with susceptibility to ovarian cancer in the Polish population.
Mostowska A; Sajdak S; Pawlik P; Markowska J; Pawałowska M; Lianeri M; Jagodzinski PP
Pathol Oncol Res; 2015 Apr; 21(2):307-13. PubMed ID: 25173882
[TBL] [Abstract][Full Text] [Related]
4. A targeted genetic association study of epithelial ovarian cancer susceptibility.
Earp M; Winham SJ; Larson N; Permuth JB; Sicotte H; Chien J; Anton-Culver H; Bandera EV; Berchuck A; Cook LS; Cramer D; Doherty JA; Goodman MT; Levine DA; Monteiro AN; Ness RB; Pearce CL; Rossing MA; Tworoger SS; Wentzensen N; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Cunningham JM; Edwards RP; Fogarty ZC; Iversen ES; Kraft P; Larson MC; Le ND; Lin HY; Lissowska J; Modugno F; Moysich KB; Olson SH; Pike MC; Poole EM; Rider DN; Terry KL; Thompson PJ; van den Berg D; Vierkant RA; Vitonis AF; Wilkens LR; Wu AH; Yang HP; Ziogas A; Phelan CM; Schildkraut JM; Chen YA; Sellers TA; Fridley BL; Goode EL
Oncotarget; 2016 Feb; 7(7):7381-9. PubMed ID: 26848776
[TBL] [Abstract][Full Text] [Related]
5. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
Zou J; Yin F; Wang Q; Zhang W; Li L
Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Song H; Ramus SJ; Tyrer J; Bolton KL; Gentry-Maharaj A; Wozniak E; Anton-Culver H; Chang-Claude J; Cramer DW; DiCioccio R; Dörk T; Goode EL; Goodman MT; Schildkraut JM; Sellers T; Baglietto L; Beckmann MW; Beesley J; Blaakaer J; Carney ME; Chanock S; Chen Z; Cunningham JM; Dicks E; Doherty JA; Dürst M; Ekici AB; Fenstermacher D; Fridley BL; Giles G; Gore ME; De Vivo I; Hillemanns P; Hogdall C; Hogdall E; Iversen ES; Jacobs IJ; Jakubowska A; Li D; Lissowska J; Lubiński J; Lurie G; McGuire V; McLaughlin J; Medrek K; Moorman PG; Moysich K; Narod S; Phelan C; Pye C; Risch H; Runnebaum IB; Severi G; Southey M; Stram DO; Thiel FC; Terry KL; Tsai YY; Tworoger SS; Van Den Berg DJ; Vierkant RA; Wang-Gohrke S; Webb PM; Wilkens LR; Wu AH; Yang H; Brewster W; Ziogas A; ; ; ; Houlston R; Tomlinson I; Whittemore AS; Rossing MA; Ponder BA; Pearce CL; Ness RB; Menon U; Kjaer SK; Gronwald J; Garcia-Closas M; Fasching PA; Easton DF; Chenevix-Trench G; Berchuck A; Pharoah PD; Gayther SA
Nat Genet; 2009 Sep; 41(9):996-1000. PubMed ID: 19648919
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiles in serous ovarian carcinoma.
Nam EJ; Yoon H; Kim SW; Kim H; Kim YT; Kim JH; Kim JW; Kim S
Clin Cancer Res; 2008 May; 14(9):2690-5. PubMed ID: 18451233
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variants in miR-1206 (8q24.2) and miR-612 (11q13.3) affect biogenesis of mature miRNA forms.
Kim HK; Prokunina-Olsson L; Chanock SJ
PLoS One; 2012; 7(10):e47454. PubMed ID: 23077621
[TBL] [Abstract][Full Text] [Related]
9. Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer.
Dou YD; Huang T; Wang Q; Shu X; Zhao SG; Li L; Liu T; Lu G; Chan WY; Liu HB
Biochem Biophys Res Commun; 2018 Jan; 496(1):191-198. PubMed ID: 29307835
[TBL] [Abstract][Full Text] [Related]
10. Novel genetic variants in miR-191 gene and familial ovarian cancer.
Shen J; DiCioccio R; Odunsi K; Lele SB; Zhao H
BMC Cancer; 2010 Feb; 10():47. PubMed ID: 20167074
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to sporadic ovarian cancer: a systematic review.
Braem MG; Schouten LJ; Peeters PH; van den Brandt PA; Onland-Moret NC
Biochim Biophys Acta; 2011 Dec; 1816(2):132-46. PubMed ID: 21641967
[TBL] [Abstract][Full Text] [Related]
12. Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Lee YS; Cho YL
Anticancer Res; 2015 May; 35(5):2611-7. PubMed ID: 25964536
[TBL] [Abstract][Full Text] [Related]
13. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
14. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
Goode EL; Chenevix-Trench G; Song H; Ramus SJ; Notaridou M; Lawrenson K; Widschwendter M; Vierkant RA; Larson MC; Kjaer SK; Birrer MJ; Berchuck A; Schildkraut J; Tomlinson I; Kiemeney LA; Cook LS; Gronwald J; Garcia-Closas M; Gore ME; Campbell I; Whittemore AS; Sutphen R; Phelan C; Anton-Culver H; Pearce CL; Lambrechts D; Rossing MA; Chang-Claude J; Moysich KB; Goodman MT; Dörk T; Nevanlinna H; Ness RB; Rafnar T; Hogdall C; Hogdall E; Fridley BL; Cunningham JM; Sieh W; McGuire V; Godwin AK; Cramer DW; Hernandez D; Levine D; Lu K; Iversen ES; Palmieri RT; Houlston R; van Altena AM; Aben KK; Massuger LF; Brooks-Wilson A; Kelemen LE; Le ND; Jakubowska A; Lubinski J; Medrek K; Stafford A; Easton DF; Tyrer J; Bolton KL; Harrington P; Eccles D; Chen A; Molina AN; Davila BN; Arango H; Tsai YY; Chen Z; Risch HA; McLaughlin J; Narod SA; Ziogas A; Brewster W; Gentry-Maharaj A; Menon U; Wu AH; Stram DO; Pike MC; ; Beesley J; Webb PM; ; ; ; Chen X; Ekici AB; Thiel FC; Beckmann MW; Yang H; Wentzensen N; Lissowska J; Fasching PA; Despierre E; Amant F; Vergote I; Doherty J; Hein R; Wang-Gohrke S; Lurie G; Carney ME; Thompson PJ; Runnebaum I; Hillemanns P; Dürst M; Antonenkova N; Bogdanova N; Leminen A; Butzow R; Heikkinen T; Stefansson K; Sulem P; Besenbacher S; Sellers TA; Gayther SA; Pharoah PD;
Nat Genet; 2010 Oct; 42(10):874-9. PubMed ID: 20852632
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in ovarian carcinomas.
Dahiya N; Morin PJ
Endocr Relat Cancer; 2010 Mar; 17(1):F77-89. PubMed ID: 19903743
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression and identification of putative miRNA targets in ovarian cancer.
Dahiya N; Sherman-Baust CA; Wang TL; Davidson B; Shih IeM; Zhang Y; Wood W; Becker KG; Morin PJ
PLoS One; 2008 Jun; 3(6):e2436. PubMed ID: 18560586
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
[TBL] [Abstract][Full Text] [Related]
18. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.
Creighton CJ; Fountain MD; Yu Z; Nagaraja AK; Zhu H; Khan M; Olokpa E; Zariff A; Gunaratne PH; Matzuk MM; Anderson ML
Cancer Res; 2010 Mar; 70(5):1906-15. PubMed ID: 20179198
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
Lee AW; Tyrer JP; Doherty JA; Stram DA; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Spiewankiewicz B; Myers EJ; ; ; Chenevix-Trench G; Fasching PA; Beckmann MW; Ekici AB; Hein A; Vergote I; Van Nieuwenhuysen E; Lambrechts D; Wicklund KG; Eilber U; Wang-Gohrke S; Chang-Claude J; Rudolph A; Sucheston-Campbell L; Odunsi K; Moysich KB; Shvetsov YB; Thompson PJ; Goodman MT; Wilkens LR; Dörk T; Hillemanns P; Dürst M; Runnebaum IB; Bogdanova N; Pelttari LM; Nevanlinna H; Leminen A; Edwards RP; Kelley JL; Harter P; Schwaab I; Heitz F; du Bois A; Orsulic S; Lester J; Walsh C; Karlan BY; Hogdall E; Kjaer SK; Jensen A; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Southey MC; Giles GG; Bruinsma F; Wu X; Hildebrandt MA; Lu K; Liang D; Bisogna M; Levine DA; Weber RP; Schildkraut JM; Iversen ES; Berchuck A; Terry KL; Cramer DW; Tworoger SS; Poole EM; Olson SH; Orlow I; Bandera EV; Bjorge L; Tangen IL; Salvesen HB; Krakstad C; Massuger LF; Kiemeney LA; Aben KK; van Altena AM; Bean Y; Pejovic T; Kellar M; Le ND; Cook LS; Kelemen LE; Brooks-Wilson A; Lubinski J; Gronwald J; Cybulski C; Jakubowska A; Wentzensen N; Brinton LA; Lissowska J; Yang H; Nedergaard L; Lundvall L; Hogdall C; Song H; Campbell IG; Eccles D; Glasspool R; Siddiqui N; Carty K; Paul J; McNeish IA; Sieh W; McGuire V; Rothstein JH; Whittemore AS; McLaughlin JR; Risch HA; Phelan CM; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Gentry-Maharaj A; Harrington P; Pike MC; Modugno F; Rossing MA; Ness RB; Pharoah PD; Stram DO; Wu AH; Pearce CL
Gynecol Oncol; 2015 Mar; 136(3):542-8. PubMed ID: 25528498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
